The transplant diagnostics market size has grown strongly in recent years. It will grow from $2.07 billion in 2025 to $2.25 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising organ transplantation procedures, advancements in histocompatibility testing, increasing prevalence of immunogenetic disorders, expansion of transplant centers, government funding for organ donation programs.
The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to integration of ai and machine learning in testing, adoption of next-generation sequencing (NGS), expansion of personalized immunotherapy, growth of cloud-based diagnostics platforms, increased global organ donation awareness. Major trends in the forecast period include rapid histocompatibility testing, ai-powered donor-recipient matching, molecular diagnostics integration, high-throughput screening techniques, cloud-based transplant data management.
The increasing prevalence of chronic diseases is increasingly supporting the expansion of the transplant diagnostics market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly, including diabetes, heart disease, and arthritis, and often require continuous medical supervision and lifestyle modifications to manage symptoms and avoid complications. The rise in chronic diseases is largely associated with unhealthy lifestyle patterns, such as poor nutrition, lack of physical activity, and smoking, which heighten the risk of cardiovascular disease, diabetes, and obesity. Transplant diagnostics play an essential role in chronic disease care by enabling accurate monitoring of organ function and early identification of transplant-related complications. These diagnostic tools improve patient outcomes by supporting timely clinical decisions, personalized treatment strategies, and enhanced long-term organ survival. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a GP were identified with non-diabetic hyperglycemia in 2023, representing an 18% increase from 2022. As a result, the growing prevalence of chronic diseases is contributing to increased adoption of transplant diagnostics.
Leading companies operating in the transplant diagnostics market are focused on introducing advanced transplant diagnostic services to expand their market presence. Advanced transplant diagnostic services use novel tools and technologies to improve the accuracy and efficiency of pre- and post-transplant testing. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory company, launched Quest Advanced Specialized Transplant Services, offering more than 170 specialized transplant and infectious disease tests. The service includes longitudinal test trend analysis in electronic medical records, 24-hour clinical consultation support, patient education materials, and expedited testing services, with some results available within 8 to 24 hours.
In October 2024, Werfen, S.A., a Spain-based supplier of specialized diagnostic instruments and reagents, acquired Omixon Biocomputing Ltd. for approximately $25 million. Through this acquisition, Werfen aims to strengthen and expand its transplant diagnostics portfolio in hospitals and clinical laboratories by incorporating Omixon’s advanced next-generation sequencing and bioinformatics technologies. Omixon Biocomputing Ltd. is a Hungary-based molecular diagnostics company specializing in transplant diagnostic solutions.
Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc.
North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the transplant diagnostics market by increasing costs for imported reagents, molecular assay kits, and sequencing instruments. Hospitals and transplant centers in regions like North America and Europe are most impacted, particularly for high-end molecular assays. While cost pressures have slowed some procurement, tariffs have also encouraged local manufacturing of reagents and instruments, stimulating regional market growth and innovation.
The transplant diagnostics market research report is one of a series of new reports that provides transplant diagnostics market statistics, including transplant diagnostics industry global market size, regional shares, competitors with a transplant diagnostics market share, detailed transplant diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the transplant diagnostics industry. This transplant diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Transplant diagnostics refer to tests performed before organ or tissue transplantation. They primarily focus on histocompatibility and immunogenetics to evaluate compatibility between donor and recipient, particularly in organ transplants and hematopoietic stem cell transplants.
The main product categories in the transplant diagnostics market include reagents and consumables, instruments, and software and services. Transplant diagnostic instruments are designed to enhance the speed and accuracy of transplant-related testing. The technologies include non-molecular assays and molecular assays used for transplantation of organs such as the kidney, liver, heart, lung, and pancreas. The transplant types include solid organ and stem cell transplants, and these solutions are used by end users such as hospitals and transplant centers, research laboratories, and commercial service providers.
The transplant diagnostics market includes revenues earned by entities by PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to integration of ai and machine learning in testing, adoption of next-generation sequencing (NGS), expansion of personalized immunotherapy, growth of cloud-based diagnostics platforms, increased global organ donation awareness. Major trends in the forecast period include rapid histocompatibility testing, ai-powered donor-recipient matching, molecular diagnostics integration, high-throughput screening techniques, cloud-based transplant data management.
The increasing prevalence of chronic diseases is increasingly supporting the expansion of the transplant diagnostics market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly, including diabetes, heart disease, and arthritis, and often require continuous medical supervision and lifestyle modifications to manage symptoms and avoid complications. The rise in chronic diseases is largely associated with unhealthy lifestyle patterns, such as poor nutrition, lack of physical activity, and smoking, which heighten the risk of cardiovascular disease, diabetes, and obesity. Transplant diagnostics play an essential role in chronic disease care by enabling accurate monitoring of organ function and early identification of transplant-related complications. These diagnostic tools improve patient outcomes by supporting timely clinical decisions, personalized treatment strategies, and enhanced long-term organ survival. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a GP were identified with non-diabetic hyperglycemia in 2023, representing an 18% increase from 2022. As a result, the growing prevalence of chronic diseases is contributing to increased adoption of transplant diagnostics.
Leading companies operating in the transplant diagnostics market are focused on introducing advanced transplant diagnostic services to expand their market presence. Advanced transplant diagnostic services use novel tools and technologies to improve the accuracy and efficiency of pre- and post-transplant testing. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory company, launched Quest Advanced Specialized Transplant Services, offering more than 170 specialized transplant and infectious disease tests. The service includes longitudinal test trend analysis in electronic medical records, 24-hour clinical consultation support, patient education materials, and expedited testing services, with some results available within 8 to 24 hours.
In October 2024, Werfen, S.A., a Spain-based supplier of specialized diagnostic instruments and reagents, acquired Omixon Biocomputing Ltd. for approximately $25 million. Through this acquisition, Werfen aims to strengthen and expand its transplant diagnostics portfolio in hospitals and clinical laboratories by incorporating Omixon’s advanced next-generation sequencing and bioinformatics technologies. Omixon Biocomputing Ltd. is a Hungary-based molecular diagnostics company specializing in transplant diagnostic solutions.
Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc.
North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the transplant diagnostics market by increasing costs for imported reagents, molecular assay kits, and sequencing instruments. Hospitals and transplant centers in regions like North America and Europe are most impacted, particularly for high-end molecular assays. While cost pressures have slowed some procurement, tariffs have also encouraged local manufacturing of reagents and instruments, stimulating regional market growth and innovation.
The transplant diagnostics market research report is one of a series of new reports that provides transplant diagnostics market statistics, including transplant diagnostics industry global market size, regional shares, competitors with a transplant diagnostics market share, detailed transplant diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the transplant diagnostics industry. This transplant diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Transplant diagnostics refer to tests performed before organ or tissue transplantation. They primarily focus on histocompatibility and immunogenetics to evaluate compatibility between donor and recipient, particularly in organ transplants and hematopoietic stem cell transplants.
The main product categories in the transplant diagnostics market include reagents and consumables, instruments, and software and services. Transplant diagnostic instruments are designed to enhance the speed and accuracy of transplant-related testing. The technologies include non-molecular assays and molecular assays used for transplantation of organs such as the kidney, liver, heart, lung, and pancreas. The transplant types include solid organ and stem cell transplants, and these solutions are used by end users such as hospitals and transplant centers, research laboratories, and commercial service providers.
The transplant diagnostics market includes revenues earned by entities by PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Transplant Diagnostics Market Characteristics
3. Transplant Diagnostics Market Supply Chain Analysis
4. Global Transplant Diagnostics Market Trends and Strategies
5. Transplant Diagnostics Market Analysis of End Use Industries
7. Global Transplant Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Transplant Diagnostics Total Addressable Market (TAM) Analysis for the Market
9. Transplant Diagnostics Market Segmentation
10. Transplant Diagnostics Market Regional and Country Analysis
11. Asia-Pacific Transplant Diagnostics Market
12. China Transplant Diagnostics Market
13. India Transplant Diagnostics Market
14. Japan Transplant Diagnostics Market
15. Australia Transplant Diagnostics Market
16. Indonesia Transplant Diagnostics Market
17. South Korea Transplant Diagnostics Market
18. Taiwan Transplant Diagnostics Market
19. South East Asia Transplant Diagnostics Market
20. Western Europe Transplant Diagnostics Market
21. UK Transplant Diagnostics Market
22. Germany Transplant Diagnostics Market
23. France Transplant Diagnostics Market
24. Italy Transplant Diagnostics Market
25. Spain Transplant Diagnostics Market
26. Eastern Europe Transplant Diagnostics Market
27. Russia Transplant Diagnostics Market
28. North America Transplant Diagnostics Market
29. USA Transplant Diagnostics Market
30. Canada Transplant Diagnostics Market
31. South America Transplant Diagnostics Market
32. Brazil Transplant Diagnostics Market
33. Middle East Transplant Diagnostics Market
34. Africa Transplant Diagnostics Market
36. Transplant Diagnostics Market Competitive Landscape and Company Profiles
37. Transplant Diagnostics Market Other Major and Innovative Companies
40. Transplant Diagnostics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Transplant Diagnostics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses transplant diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for transplant diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transplant diagnostics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Reagent And Consumables; Instrument; Software And Services2) By Transplant Type: Solid Organ; Stem Cell
3) By Organ: Kidney; Liver; Heart; Lung; Pancreas
4) By Technology: Non Molecular Assay; Molecular Assay
5) By End User: Hospitals And Transplant Centers; Research Laboratories AndTransplant Centers; Commercial Service Providers
Subsegments:
1) By Reagent And Consumables: PCR Reagents; Antibodies And Antigens; Sample Collection Kits; Control Materials2) By Instrument: Flow Cytometers; PCR Machines; Sequencers; Luminometers
3) By Software And Services: Data Analysis Software; Laboratory Information Management Systems (LIMS); Consulting Services; Technical Support And Maintenance Services
Companies Mentioned: F. Hoffmann La-Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Becton-Dickinson and Company; Hologic Inc.; Illumina Inc.; BioMerieus S.A; Biomérieux SA; Grafton Companies; Bio-rad Laboratories Inc.; Sigma-Aldrich Corporation; Qiagen N.V.; Immucor Transplant Diagnostics Inc.; Immucor Inc.; Luminex Corporation; Affymetrix Inc.; CareDx Company; One Lambda Inc.; Eurobio Scientific Group; Gendx BV; Olerup SSp AB; Genome Diagnostics B.V.; Transplant Genomics Inc.; Omixon Ltd.; BAG Healthcare GmbH; Histogenetics Inc.; Linkage Biosciences lnc.; Gendrive plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Transplant Diagnostics market report include:- F. Hoffmann La-Roche AG
- Thermo Fisher Scientific Inc.
- Abbott Laboratories Inc.
- Becton-Dickinson and Company
- Hologic Inc.
- Illumina Inc.
- BioMerieus S.A
- Biomérieux SA
- Grafton Companies
- Bio-rad Laboratories Inc.
- Sigma-Aldrich Corporation
- Qiagen N.V.
- Immucor Transplant Diagnostics Inc.
- Immucor Inc.
- Luminex Corporation
- Affymetrix Inc.
- CareDx Company
- One Lambda Inc.
- Eurobio Scientific Group
- Gendx BV
- Olerup SSp AB
- Genome Diagnostics B.V.
- Transplant Genomics Inc.
- Omixon Ltd.
- BAG Healthcare GmbH
- Histogenetics Inc.
- Linkage Biosciences lnc.
- Gendrive plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.25 Billion |
| Forecasted Market Value ( USD | $ 2.96 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
